COVID-19 Diagnostics Market Size, Share, Trends, Industry Analysis Report: By Product Type, Sample Type, Test Type, and Region

Description

List of Tables

The global COVID-19 diagnostics market size is expected to reach USD 7.26 billion by 2034, according to a new study by Polaris Market Research. The report "COVID-19 Diagnostics Market Size, Share, Trends, Industry Analysis Report: By Product Type (Reagents & Kits, Instruments, and Others), Sample Type, Test Type, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The rising COVID-19 diagnostics market demand is attributed to the need for effective testing solutions to manage global outbreaks, high demand for rapid and accurate testing, government initiatives to increase testing capacity, and advancements in diagnostic technologies. Opportunities exist in the growing adoption of at-home testing kits, the integration of AI and digital platforms for improved diagnostics, and the development of multiplex tests that can detect multiple infections at once.

Emerging COVID-19 diagnostics market trends such as point-of-care testing and increasing focus on detecting new virus variants are shaping the market. Overall, the market is poised for continued growth as governments, healthcare organizations, and consumers seek efficient, accessible, and scalable testing solutions to combat the pandemic and prepare for future health challenges.

COVID-19 Diagnostics Market Report Highlights

By product type, the reagents & kits segment holds the largest share of the COVID-19 diagnostics market revenue, driven by their essential role in widespread testing, especially for PCR and rapid antigen tests. The instruments segment is registering the highest growth, fueled by advancements in automated diagnostic systems and increasing demand for high-throughput testing solutions.

Based on sample type, the swabs segment dominates the COVID-19 diagnostics market share. It is the primary method for collecting samples for molecular and antigen tests, particularly in clinical and public health settings. The blood samples segment is experiencing the highest growth, mainly due to the increasing use of antibody and serology tests for post-infection surveillance and immunity assessment.

The molecular (RT-PCR) testing segment continues to dominate the market, regarded as the most accurate method for detecting active COVID-19 infections. However, the antigen-based testing segment is experiencing the highest growth, driven by its rapid result delivery and ease of use, especially in point-of-care and at-home settings.

North America holds the largest market share, with strong healthcare infrastructure and high testing demand, particularly in the US. Asia Pacific is the highest-growing region, driven by the rapid scaling of testing efforts in densely populated countries such as India and China, alongside innovations in point-of-care testing solutions.

Polaris Market Research has segmented the COVID-19 diagnostics market report on the basis of product type, sample type, test type, and region:

By Product Type Outlook (Revenue - USD Billion, 2020-2034)

Reagents & Kits
Instruments
Others

By Sample Type Outlook (Revenue - USD Billion, 2020-2034)

Swabs
Blood
Others

By Test Type Outlook (Revenue - USD Billion, 2020-2034)

Molecular (RT-PCR) Testing
Antigen-Based Testing
Antibody (Serology)

By Regional Outlook (Revenue - USD Billion, 2020-2034)

North America
US
Canada
Europe
Germany
France
UK
Italy
Spain
Netherlands
Russia
Rest of Europe
Asia Pacific
China
Japan
India
Malaysia
South Korea
Indonesia
Australia
Vietnam
Rest of Asia Pacific
Middle East & Africa
Saudi Arabia
UAE
Israel
South Africa
Rest of Middle East & Africa
Latin America
Mexico
Brazil
Argentina
Rest of Latin America

Product Code: PM1752

1. Introduction

1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary

2.1. Market Highlights

3. Research Methodology

3.1. Overview
- 3.1.1. Data Mining
3.2. Data Source
- 3.2.1. Primary Source
- 3.2.2. Secondary Source

4. Global Covid-19 Diagnostics Market Insights

4.1. Covid-19 Diagnostics Market - Market Snapshot
4.2. Covid-19 Diagnostics Market Dynamics
- 4.2.1. Drivers and Opportunities
  - 4.2.1.1. Rising Demand for Point-of-Care Testing Solutions
  - 4.2.1.2. Integration of Advanced Technologies in Diagnostics
  - 4.2.1.3. Growing Popularity of At-Home Testing Kits
- 4.2.2. Restraints and Challenges
  - 4.2.2.1. Insufficient Trained Personnel
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. Covid-19 Diagnostics Market Test Type Trends
4.6. Value Chain Analysis
4.7. COVID-19 Impact Analysis

5. Global Covid-19 Diagnostics Market, by Product Type

5.1. Key Findings
5.2. Introduction
- 5.2.1. Global Covid-19 Diagnostics Market, by Product Type, 2020-2034 (USD Billion)
5.3. Reagents & Kits
- 5.3.1. Global Covid-19 Diagnostics Market, by Reagents & Kits, by Region, 2020-2034 (USD Billion)
5.4. Instruments
- 5.4.1. Global Covid-19 Diagnostics Market, by Instruments, by Region, 2020-2034 (USD Billion)
5.5. Others
- 5.5.1. Global Covid-19 Diagnostics Market, by Others, by Region, 2020-2034 (USD Billion)

6. Global Covid-19 Diagnostics Market, by Sample Type

6.1. Key Findings
6.2. Introduction
- 6.2.1. Global Covid-19 Diagnostics Market, by Sample Type, 2020-2034 (USD Billion)
6.3. Swabs
- 6.3.1. Global Covid-19 Diagnostics Market, by Swabs, by Region, 2020-2034 (USD Billion)
6.4. Blood
- 6.4.1. Global Covid-19 Diagnostics Market, by Blood, by Region, 2020-2034 (USD Billion)
6.5. Others
- 6.5.1. Global Covid-19 Diagnostics Market, by Others, by Region, 2020-2034 (USD Billion)

7. Global Covid-19 Diagnostics Market, by Test Type

7.1. Key Findings
7.2. Introduction
- 7.2.1. Global Covid-19 Diagnostics Market, by Test Type, 2020-2034 (USD Billion)
7.3. Molecular (RT-PCR) Testing
- 7.3.1. Global Covid-19 Diagnostics Market, by Molecular (RT-PCR) Testing, by Region, 2020-2034 (USD Billion)
7.4. Antigen-Based Testing
- 7.4.1. Global Covid-19 Diagnostics Market, by Antigen-Based Testing, by Region, 2020-2034 (USD Billion)
7.5. Antibody (Serology)
- 7.5.1. Global Covid-19 Diagnostics Market, by Antibody (Serology), by Region, 2020-2034 (USD Billion)

8. Global Covid-19 Diagnostics Market, by Geography

8.1. Key Findings
8.2. Introduction
- 8.2.1. Covid-19 Diagnostics Market Assessment, By Geography, 2020-2034 (USD Billion)
8.3. Covid-19 Diagnostics Market - North America
- 8.3.1. North America: Covid-19 Diagnostics Market, by Product Type, 2020-2034 (USD Billion)
- 8.3.2. North America: Covid-19 Diagnostics Market, by Sample Type, 2020-2034 (USD Billion)
- 8.3.3. North America: Covid-19 Diagnostics Market, by Test Type, 2020-2034 (USD Billion)
- 8.3.4. Covid-19 Diagnostics Market - U.S.
  - 8.3.4.1. U.S.: Covid-19 Diagnostics Market, by Product Type, 2020-2034 (USD Billion)
  - 8.3.4.2. U.S.: Covid-19 Diagnostics Market, by Sample Type, 2020-2034 (USD Billion)
  - 8.3.4.3. U.S.: Covid-19 Diagnostics Market, by Test Type, 2020-2034 (USD Billion)
- 8.3.5. Covid-19 Diagnostics Market - Canada
  - 8.3.5.1. Canada: Covid-19 Diagnostics Market, by Product Type, 2020-2034 (USD Billion)
  - 8.3.5.2. Canada: Covid-19 Diagnostics Market, by Sample Type, 2020-2034 (USD Billion)
  - 8.3.5.3. Canada: Covid-19 Diagnostics Market, by Test Type, 2020-2034 (USD Billion)
8.4. Covid-19 Diagnostics Market - Europe
- 8.4.1. Europe: Covid-19 Diagnostics Market, by Product Type, 2020-2034 (USD Billion)
- 8.4.2. Europe: Covid-19 Diagnostics Market, by Sample Type, 2020-2034 (USD Billion)
- 8.4.3. Europe: Covid-19 Diagnostics Market, by Test Type, 2020-2034 (USD Billion)
- 8.4.4. Covid-19 Diagnostics Market - UK
  - 8.4.4.1. UK: Covid-19 Diagnostics Market, by Product Type, 2020-2034 (USD Billion)
  - 8.4.4.2. UK: Covid-19 Diagnostics Market, by Sample Type, 2020-2034 (USD Billion)
  - 8.4.4.3. UK: Covid-19 Diagnostics Market, by Test Type, 2020-2034 (USD Billion)
- 8.4.5. Covid-19 Diagnostics Market - France
  - 8.4.5.1. France: Covid-19 Diagnostics Market, by Product Type, 2020-2034 (USD Billion)
  - 8.4.5.2. France: Covid-19 Diagnostics Market, by Sample Type, 2020-2034 (USD Billion)
  - 8.4.5.3. France: Covid-19 Diagnostics Market, by Test Type, 2020-2034 (USD Billion)
- 8.4.6. Covid-19 Diagnostics Market - Germany
  - 8.4.6.1. Germany: Covid-19 Diagnostics Market, by Product Type, 2020-2034 (USD Billion)
  - 8.4.6.2. Germany: Covid-19 Diagnostics Market, by Sample Type, 2020-2034 (USD Billion)
  - 8.4.6.3. Germany: Covid-19 Diagnostics Market, by Test Type, 2020-2034 (USD Billion)
- 8.4.7. Covid-19 Diagnostics Market - Italy
  - 8.4.7.1. Italy: Covid-19 Diagnostics Market, by Product Type, 2020-2034 (USD Billion)
  - 8.4.7.2. Italy: Covid-19 Diagnostics Market, by Sample Type, 2020-2034 (USD Billion)
  - 8.4.7.3. Italy: Covid-19 Diagnostics Market, by Test Type, 2020-2034 (USD Billion)
- 8.4.8. Covid-19 Diagnostics Market - Spain
  - 8.4.8.1. Spain: Covid-19 Diagnostics Market, by Product Type, 2020-2034 (USD Billion)
  - 8.4.8.2. Spain: Covid-19 Diagnostics Market, by Sample Type, 2020-2034 (USD Billion)
  - 8.4.8.3. Spain: Covid-19 Diagnostics Market, by Test Type, 2020-2034 (USD Billion)
- 8.4.9. Covid-19 Diagnostics Market - Netherlands
  - 8.4.9.1. Netherlands: Covid-19 Diagnostics Market, by Product Type, 2020-2034 (USD Billion)
  - 8.4.9.2. Netherlands: Covid-19 Diagnostics Market, by Sample Type, 2020-2034 (USD Billion)
  - 8.4.9.3. Netherlands: Covid-19 Diagnostics Market, by Test Type, 2020-2034 (USD Billion)
- 8.4.10. Covid-19 Diagnostics Market - Russia
  - 8.4.10.1. Russia: Covid-19 Diagnostics Market, by Product Type, 2020-2034 (USD Billion)
  - 8.4.10.2. Russia: Covid-19 Diagnostics Market, by Sample Type, 2020-2034 (USD Billion)
  - 8.4.10.3. Russia: Covid-19 Diagnostics Market, by Test Type, 2020-2034 (USD Billion)
- 8.4.11. Covid-19 Diagnostics Market - Rest of Europe
  - 8.4.11.1. Rest of Europe: Covid-19 Diagnostics Market, by Product Type, 2020-2034 (USD Billion)
  - 8.4.11.2. Rest of Europe: Covid-19 Diagnostics Market, by Sample Type, 2020-2034 (USD Billion)
  - 8.4.11.3. Rest of Europe: Covid-19 Diagnostics Market, by Test Type, 2020-2034 (USD Billion)
8.5. Covid-19 Diagnostics Market - Asia Pacific
- 8.5.1. Asia Pacific: Covid-19 Diagnostics Market, by Product Type, 2020-2034 (USD Billion)
- 8.5.2. Asia Pacific: Covid-19 Diagnostics Market, by Sample Type, 2020-2034 (USD Billion)
- 8.5.3. Asia Pacific: Covid-19 Diagnostics Market, by Test Type, 2020-2034 (USD Billion)
- 8.5.4. Covid-19 Diagnostics Market - China
  - 8.5.4.1. China: Covid-19 Diagnostics Market, by Product Type, 2020-2034 (USD Billion)
  - 8.5.4.2. China: Covid-19 Diagnostics Market, by Sample Type, 2020-2034 (USD Billion)
  - 8.5.4.3. China: Covid-19 Diagnostics Market, by Test Type, 2020-2034 (USD Billion)
- 8.5.5. Covid-19 Diagnostics Market - India
  - 8.5.5.1. India: Covid-19 Diagnostics Market, by Product Type, 2020-2034 (USD Billion)
  - 8.5.5.2. India: Covid-19 Diagnostics Market, by Sample Type, 2020-2034 (USD Billion)
  - 8.5.5.3. India: Covid-19 Diagnostics Market, by Test Type, 2020-2034 (USD Billion)
- 8.5.6. Covid-19 Diagnostics Market - Malaysia
  - 8.5.6.1. Malaysia: Covid-19 Diagnostics Market, by Product Type, 2020-2034 (USD Billion)
  - 8.5.6.2. Malaysia: Covid-19 Diagnostics Market, by Sample Type, 2020-2034 (USD Billion)
  - 8.5.6.3. Malaysia: Covid-19 Diagnostics Market, by Test Type, 2020-2034 (USD Billion)
- 8.5.7. Covid-19 Diagnostics Market - Japan
  - 8.5.7.1. Japan: Covid-19 Diagnostics Market, by Product Type, 2020-2034 (USD Billion)
  - 8.5.7.2. Japan: Covid-19 Diagnostics Market, by Sample Type, 2020-2034 (USD Billion)
  - 8.5.7.3. Japan: Covid-19 Diagnostics Market, by Test Type, 2020-2034 (USD Billion)
- 8.5.8. Covid-19 Diagnostics Market - Indonesia
  - 8.5.8.1. Indonesia: Covid-19 Diagnostics Market, by Product Type, 2020-2034 (USD Billion)
  - 8.5.8.2. Indonesia: Covid-19 Diagnostics Market, by Sample Type, 2020-2034 (USD Billion)
  - 8.5.8.3. Indonesia: Covid-19 Diagnostics Market, by Test Type, 2020-2034 (USD Billion)
- 8.5.9. Covid-19 Diagnostics Market - South Korea
  - 8.5.9.1. South Korea: Covid-19 Diagnostics Market, by Product Type, 2020-2034 (USD Billion)
  - 8.5.9.2. South Korea: Covid-19 Diagnostics Market, by Sample Type, 2020-2034 (USD Billion)
  - 8.5.9.3. South Korea: Covid-19 Diagnostics Market, by Test Type, 2020-2034 (USD Billion)
- 8.5.10. Covid-19 Diagnostics Market - Australia
  - 8.5.10.1. Australia: Covid-19 Diagnostics Market, by Product Type, 2020-2034 (USD Billion)
  - 8.5.10.2. Australia: Covid-19 Diagnostics Market, by Sample Type, 2020-2034 (USD Billion)
  - 8.5.10.3. Australia: Covid-19 Diagnostics Market, by Test Type, 2020-2034 (USD Billion)
- 8.5.11. Covid-19 Diagnostics Market - Rest of Asia Pacific
  - 8.5.11.1. Rest of Asia Pacific: Covid-19 Diagnostics Market, by Product Type, 2020-2034 (USD Billion)
  - 8.5.11.2. Rest of Asia Pacific: Covid-19 Diagnostics Market, by Sample Type, 2020-2034 (USD Billion)
  - 8.5.11.3. Rest of Asia Pacific: Covid-19 Diagnostics Market, by Test Type, 2020-2034 (USD Billion)
8.6. Covid-19 Diagnostics Market - Middle East & Africa
- 8.6.1. Middle East & Africa: Covid-19 Diagnostics Market, by Product Type, 2020-2034 (USD Billion)
- 8.6.2. Middle East & Africa: Covid-19 Diagnostics Market, by Sample Type, 2020-2034 (USD Billion)
- 8.6.3. Middle East & Africa: Covid-19 Diagnostics Market, by Test Type, 2020-2034 (USD Billion)
- 8.6.4. Covid-19 Diagnostics Market - Saudi Arabia
  - 8.6.4.1. Saudi Arabia: Covid-19 Diagnostics Market, by Product Type, 2020-2034 (USD Billion)
  - 8.6.4.2. Saudi Arabia: Covid-19 Diagnostics Market, by Sample Type, 2020-2034 (USD Billion)
  - 8.6.4.3. Saudi Arabia: Covid-19 Diagnostics Market, by Test Type, 2020-2034 (USD Billion)
- 8.6.5. Covid-19 Diagnostics Market - UAE
  - 8.6.5.1. UAE: Covid-19 Diagnostics Market, by Product Type, 2020-2034 (USD Billion)
  - 8.6.5.2. UAE: Covid-19 Diagnostics Market, by Sample Type, 2020-2034 (USD Billion)
  - 8.6.5.3. UAE: Covid-19 Diagnostics Market, by Test Type, 2020-2034 (USD Billion)
- 8.6.6. Covid-19 Diagnostics Market - Israel
  - 8.6.6.1. Israel: Covid-19 Diagnostics Market, by Product Type, 2020-2034 (USD Billion)
  - 8.6.6.2. Israel: Covid-19 Diagnostics Market, by Sample Type, 2020-2034 (USD Billion)
  - 8.6.6.3. Israel: Covid-19 Diagnostics Market, by Test Type, 2020-2034 (USD Billion)
- 8.6.7. Covid-19 Diagnostics Market - South Africa
  - 8.6.7.1. South Africa: Covid-19 Diagnostics Market, by Product Type, 2020-2034 (USD Billion)
  - 8.6.7.2. South Africa: Covid-19 Diagnostics Market, by Sample Type, 2020-2034 (USD Billion)
  - 8.6.7.3. South Africa: Covid-19 Diagnostics Market, by Test Type, 2020-2034 (USD Billion)
- 8.6.8. Covid-19 Diagnostics Market - Rest of Middle East & Africa
  - 8.6.8.1. Rest of Middle East & Africa: Covid-19 Diagnostics Market, by Product Type, 2020-2034 (USD Billion)
  - 8.6.8.2. Rest of Middle East & Africa: Covid-19 Diagnostics Market, by Sample Type, 2020-2034 (USD Billion)
  - 8.6.8.3. Rest of Middle East & Africa: Covid-19 Diagnostics Market, by Test Type, 2020-2034 (USD Billion)
8.7. Covid-19 Diagnostics Market - Latin America
- 8.7.1. Latin America: Covid-19 Diagnostics Market, by Product Type, 2020-2034 (USD Billion)
- 8.7.2. Latin America: Covid-19 Diagnostics Market, by Sample Type, 2020-2034 (USD Billion)
- 8.7.3. Latin America: Covid-19 Diagnostics Market, by Test Type, 2020-2034 (USD Billion)
- 8.7.4. Covid-19 Diagnostics Market - Mexico
  - 8.7.4.1. Mexico: Covid-19 Diagnostics Market, by Product Type, 2020-2034 (USD Billion)
  - 8.7.4.2. Mexico: Covid-19 Diagnostics Market, by Sample Type, 2020-2034 (USD Billion)
  - 8.7.4.3. Mexico: Covid-19 Diagnostics Market, by Test Type, 2020-2034 (USD Billion)
- 8.7.5. Covid-19 Diagnostics Market - Brazil
  - 8.7.5.1. Brazil: Covid-19 Diagnostics Market, by Product Type, 2020-2034 (USD Billion)
  - 8.7.5.2. Brazil: Covid-19 Diagnostics Market, by Sample Type, 2020-2034 (USD Billion)
  - 8.7.5.3. Brazil: Covid-19 Diagnostics Market, by Test Type, 2020-2034 (USD Billion)
- 8.7.6. Covid-19 Diagnostics Market - Argentina
  - 8.7.6.1. Argentina: Covid-19 Diagnostics Market, by Product Type, 2020-2034 (USD Billion)
  - 8.7.6.2. Argentina: Covid-19 Diagnostics Market, by Sample Type, 2020-2034 (USD Billion)
  - 8.7.6.3. Argentina: Covid-19 Diagnostics Market, by Test Type, 2020-2034 (USD Billion)
- 8.7.7. Covid-19 Diagnostics Market - Rest of Latin America
  - 8.7.7.1. Rest of Latin America: Covid-19 Diagnostics Market, by Product Type, 2020-2034 (USD Billion)
  - 8.7.7.2. Rest of Latin America: Covid-19 Diagnostics Market, by Sample Type, 2020-2034 (USD Billion)
  - 8.7.7.3. Rest of Latin America: Covid-19 Diagnostics Market, by Test Type, 2020-2034 (USD Billion)

9. Competitive Landscape

9.1. Expansion and Acquisition Analysis
- 9.1.1. Expansion
- 9.1.2. Acquisitions
9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

10.1. Abbott Laboratories
- 10.1.1. Company Overview
- 10.1.2. Financial Performance
- 10.1.3. Product Benchmarking
- 10.1.4. Recent Development
10.2. Roche Diagnostics
- 10.2.1. Company Overview
- 10.2.2. Financial Performance
- 10.2.3. Product Benchmarking
- 10.2.4. Recent Development
10.3. Thermo Fisher Scientific
- 10.3.1. Company Overview
- 10.3.2. Financial Performance
- 10.3.3. Product Benchmarking
- 10.3.4. Recent Development
10.4. Siemens Healthineers
- 10.4.1. Company Overview
- 10.4.2. Financial Performance
- 10.4.3. Product Benchmarking
- 10.4.4. Recent Development
10.5. BioMerieux
- 10.5.1. Company Overview
- 10.5.2. Financial Performance
- 10.5.3. Product Benchmarking
- 10.5.4. Recent Development
10.6. PerkinElmer
- 10.6.1. Company Overview
- 10.6.2. Financial Performance
- 10.6.3. Product Benchmarking
- 10.6.4. Recent Development
10.7. Danaher Corporation
- 10.7.1. Company Overview
- 10.7.2. Financial Performance
- 10.7.3. Product Benchmarking
- 10.7.4. Recent Development
10.8. Quidel Corporation
- 10.8.1. Company Overview
- 10.8.2. Financial Performance
- 10.8.3. Product Benchmarking
- 10.8.4. Recent Development
10.9. Hologic
- 10.9.1. Company Overview
- 10.9.2. Financial Performance
- 10.9.3. Product Benchmarking
- 10.9.4. Recent Development
10.10. Becton Dickinson
- 10.10.1. Company Overview
- 10.10.2. Financial Performance
- 10.10.3. Product Benchmarking
- 10.10.4. Recent Development
10.11. Cepheid
- 10.11.1. Company Overview
- 10.11.2. Financial Performance
- 10.11.3. Product Benchmarking
- 10.11.4. Recent Development
10.12. Grifols
- 10.12.1. Company Overview
- 10.12.2. Financial Performance
- 10.12.3. Product Benchmarking
- 10.12.4. Recent Development
10.13. Stryker Corporation
- 10.13.1. Company Overview
- 10.13.2. Financial Performance
- 10.13.3. Product Benchmarking
- 10.13.4. Recent Development
10.14. Zhejiang Orient Gene Biotech
- 10.14.1. Company Overview
- 10.14.2. Financial Performance
- 10.14.3. Product Benchmarking
- 10.14.4. Recent Development
10.15. BGI Genomics
- 10.15.1. Company Overview
- 10.15.2. Financial Performance
- 10.15.3. Product Benchmarking
- 10.15.4. Recent Development